Microbix Biosystems Inc. (TSX:MBX)

SolarWinds Revenue

Microbix Biosystems had revenue of 5.32M CAD in the quarter ending March 31, 2025, a decrease of -5.47%. This brings the company's revenue in the last twelve months to 22.72M, down -4.67% year-over-year. In the fiscal year ending September 30, 2024, Microbix Biosystems had annual revenue of 25.39M with 53.77% growth.

• Revenue (ttm): 22.72M
• Revenue Growth: -4.67%
• P/S Ratio: 1.82
• Revenue / Employee: 227.22K
• Employees: 70
• Market Cap: 41.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	25.39M	8.88M	53.77%
Sep 30, 2023	16.51M	-2.56M	-13.43%
Sep 30, 2022	19.08M	483.28K	2.60%
Sep 30, 2021	18.59M	8.07M	76.66%
Sep 30, 2020	10.52M	-2.89M	-21.53%